CD82 controls CpG-dependent TLR9 signaling. 2019

Nida S Khan, and Daniel P Lukason, and Marianela Feliu, and Rebecca A Ward, and Allison K Lord, and Jennifer L Reedy, and Zaida G Ramirez-Ortiz, and Jenny M Tam, and Pia V Kasperkovitz, and Paige E Negoro, and Tammy D Vyas, and Shuying Xu, and Melanie M Brinkmann, and Mridu Acharaya, and Katerina Artavanis-Tsakonas, and Eva-Maria Frickel, and Christine E Becker, and Zeina Dagher, and You-Me Kim, and Eicke Latz, and Hidde L Ploegh, and Michael K Mansour, and Cindy K Miranti, and Stuart M Levitz, and Jatin M Vyas
Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.

The tetraspanin CD82 is a potent suppressor of tumor metastasis and regulates several processes including signal transduction, cell adhesion, motility, and aggregation. However, the mechanisms by which CD82 participates in innate immunity are unknown. We report that CD82 is a key regulator of TLR9 trafficking and signaling. TLR9 recognizes unmethylated cytosine-phosphate-guanine (CpG) motifs present in viral, bacterial, and fungal DNA. We demonstrate that TLR9 and CD82 associate in macrophages, which occurs in the endoplasmic reticulum (ER) and post-ER. Moreover, CD82 is essential for TLR9-dependent myddosome formation in response to CpG stimulation. Finally, CD82 modulates TLR9-dependent NF-κB nuclear translocation, which is critical for inflammatory cytokine production. To our knowledge, this is the first time a tetraspanin has been implicated as a key regulator of TLR signaling. Collectively, our study demonstrates that CD82 is a specific regulator of TLR9 signaling, which may be critical in cancer immunotherapy approaches and coordinating the innate immune response to pathogens.-Khan, N. S., Lukason, D. P., Feliu, M., Ward, R. A., Lord, A. K., Reedy, J. L., Ramirez-Ortiz, Z. G., Tam, J. M., Kasperkovitz, P. V., Negoro, P. E., Vyas, T. D., Xu, S., Brinkmann, M. M., Acharaya, M., Artavanis-Tsakonas, K., Frickel, E.-M., Becker, C. E., Dagher, Z., Kim, Y.-M., Latz, E., Ploegh, H. L., Mansour, M. K., Miranti, C. K., Levitz, S. M., Vyas, J. M. CD82 controls CpG-dependent TLR9 signaling.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D009838 Oligodeoxyribonucleotides A group of deoxyribonucleotides (up to 12) in which the phosphate residues of each deoxyribonucleotide act as bridges in forming diester linkages between the deoxyribose moieties. Oligodeoxynucleotide,Oligodeoxyribonucleotide,Oligodeoxynucleotides
D002467 Cell Nucleus Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Cell Nuclei,Nuclei, Cell,Nucleus, Cell
D004721 Endoplasmic Reticulum A system of cisternae in the CYTOPLASM of many cells. In places the endoplasmic reticulum is continuous with the plasma membrane (CELL MEMBRANE) or outer membrane of the nuclear envelope. If the outer surfaces of the endoplasmic reticulum membranes are coated with ribosomes, the endoplasmic reticulum is said to be rough-surfaced (ENDOPLASMIC RETICULUM, ROUGH); otherwise it is said to be smooth-surfaced (ENDOPLASMIC RETICULUM, SMOOTH). (King & Stansfield, A Dictionary of Genetics, 4th ed) Ergastoplasm,Reticulum, Endoplasmic
D000067996 RAW 264.7 Cells A transformed macrophage cell line isolated from ASCITES of mice infected with ABELSON MURINE LEUKEMIA VIRUS. RAW 264.7 Cell Line,264.7 Cell, RAW,264.7 Cells, RAW,Cell, RAW 264.7,Cells, RAW 264.7,RAW 264.7 Cell
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine
D016328 NF-kappa B Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA. Immunoglobulin Enhancer-Binding Protein,NF-kappa B Complex,Nuclear Factor kappa B,Transcription Factor NF-kB,kappa B Enhancer Binding Protein,Ig-EBP-1,NF-kB,NF-kappaB,Nuclear Factor-Kappab,Complex, NF-kappa B,Enhancer-Binding Protein, Immunoglobulin,Factor NF-kB, Transcription,Factor-Kappab, Nuclear,Ig EBP 1,Immunoglobulin Enhancer Binding Protein,NF kB,NF kappa B Complex,NF kappaB,NF-kB, Transcription Factor,Nuclear Factor Kappab,Transcription Factor NF kB

Related Publications

Nida S Khan, and Daniel P Lukason, and Marianela Feliu, and Rebecca A Ward, and Allison K Lord, and Jennifer L Reedy, and Zaida G Ramirez-Ortiz, and Jenny M Tam, and Pia V Kasperkovitz, and Paige E Negoro, and Tammy D Vyas, and Shuying Xu, and Melanie M Brinkmann, and Mridu Acharaya, and Katerina Artavanis-Tsakonas, and Eva-Maria Frickel, and Christine E Becker, and Zeina Dagher, and You-Me Kim, and Eicke Latz, and Hidde L Ploegh, and Michael K Mansour, and Cindy K Miranti, and Stuart M Levitz, and Jatin M Vyas
January 2018, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology,
Nida S Khan, and Daniel P Lukason, and Marianela Feliu, and Rebecca A Ward, and Allison K Lord, and Jennifer L Reedy, and Zaida G Ramirez-Ortiz, and Jenny M Tam, and Pia V Kasperkovitz, and Paige E Negoro, and Tammy D Vyas, and Shuying Xu, and Melanie M Brinkmann, and Mridu Acharaya, and Katerina Artavanis-Tsakonas, and Eva-Maria Frickel, and Christine E Becker, and Zeina Dagher, and You-Me Kim, and Eicke Latz, and Hidde L Ploegh, and Michael K Mansour, and Cindy K Miranti, and Stuart M Levitz, and Jatin M Vyas
January 2002, Current topics in microbiology and immunology,
Nida S Khan, and Daniel P Lukason, and Marianela Feliu, and Rebecca A Ward, and Allison K Lord, and Jennifer L Reedy, and Zaida G Ramirez-Ortiz, and Jenny M Tam, and Pia V Kasperkovitz, and Paige E Negoro, and Tammy D Vyas, and Shuying Xu, and Melanie M Brinkmann, and Mridu Acharaya, and Katerina Artavanis-Tsakonas, and Eva-Maria Frickel, and Christine E Becker, and Zeina Dagher, and You-Me Kim, and Eicke Latz, and Hidde L Ploegh, and Michael K Mansour, and Cindy K Miranti, and Stuart M Levitz, and Jatin M Vyas
February 2016, International journal of molecular sciences,
Nida S Khan, and Daniel P Lukason, and Marianela Feliu, and Rebecca A Ward, and Allison K Lord, and Jennifer L Reedy, and Zaida G Ramirez-Ortiz, and Jenny M Tam, and Pia V Kasperkovitz, and Paige E Negoro, and Tammy D Vyas, and Shuying Xu, and Melanie M Brinkmann, and Mridu Acharaya, and Katerina Artavanis-Tsakonas, and Eva-Maria Frickel, and Christine E Becker, and Zeina Dagher, and You-Me Kim, and Eicke Latz, and Hidde L Ploegh, and Michael K Mansour, and Cindy K Miranti, and Stuart M Levitz, and Jatin M Vyas
January 2006, Current topics in microbiology and immunology,
Nida S Khan, and Daniel P Lukason, and Marianela Feliu, and Rebecca A Ward, and Allison K Lord, and Jennifer L Reedy, and Zaida G Ramirez-Ortiz, and Jenny M Tam, and Pia V Kasperkovitz, and Paige E Negoro, and Tammy D Vyas, and Shuying Xu, and Melanie M Brinkmann, and Mridu Acharaya, and Katerina Artavanis-Tsakonas, and Eva-Maria Frickel, and Christine E Becker, and Zeina Dagher, and You-Me Kim, and Eicke Latz, and Hidde L Ploegh, and Michael K Mansour, and Cindy K Miranti, and Stuart M Levitz, and Jatin M Vyas
October 2003, Trends in immunology,
Nida S Khan, and Daniel P Lukason, and Marianela Feliu, and Rebecca A Ward, and Allison K Lord, and Jennifer L Reedy, and Zaida G Ramirez-Ortiz, and Jenny M Tam, and Pia V Kasperkovitz, and Paige E Negoro, and Tammy D Vyas, and Shuying Xu, and Melanie M Brinkmann, and Mridu Acharaya, and Katerina Artavanis-Tsakonas, and Eva-Maria Frickel, and Christine E Becker, and Zeina Dagher, and You-Me Kim, and Eicke Latz, and Hidde L Ploegh, and Michael K Mansour, and Cindy K Miranti, and Stuart M Levitz, and Jatin M Vyas
January 2017, Cell reports,
Nida S Khan, and Daniel P Lukason, and Marianela Feliu, and Rebecca A Ward, and Allison K Lord, and Jennifer L Reedy, and Zaida G Ramirez-Ortiz, and Jenny M Tam, and Pia V Kasperkovitz, and Paige E Negoro, and Tammy D Vyas, and Shuying Xu, and Melanie M Brinkmann, and Mridu Acharaya, and Katerina Artavanis-Tsakonas, and Eva-Maria Frickel, and Christine E Becker, and Zeina Dagher, and You-Me Kim, and Eicke Latz, and Hidde L Ploegh, and Michael K Mansour, and Cindy K Miranti, and Stuart M Levitz, and Jatin M Vyas
March 2009, Advanced drug delivery reviews,
Nida S Khan, and Daniel P Lukason, and Marianela Feliu, and Rebecca A Ward, and Allison K Lord, and Jennifer L Reedy, and Zaida G Ramirez-Ortiz, and Jenny M Tam, and Pia V Kasperkovitz, and Paige E Negoro, and Tammy D Vyas, and Shuying Xu, and Melanie M Brinkmann, and Mridu Acharaya, and Katerina Artavanis-Tsakonas, and Eva-Maria Frickel, and Christine E Becker, and Zeina Dagher, and You-Me Kim, and Eicke Latz, and Hidde L Ploegh, and Michael K Mansour, and Cindy K Miranti, and Stuart M Levitz, and Jatin M Vyas
January 2010, International archives of allergy and immunology,
Nida S Khan, and Daniel P Lukason, and Marianela Feliu, and Rebecca A Ward, and Allison K Lord, and Jennifer L Reedy, and Zaida G Ramirez-Ortiz, and Jenny M Tam, and Pia V Kasperkovitz, and Paige E Negoro, and Tammy D Vyas, and Shuying Xu, and Melanie M Brinkmann, and Mridu Acharaya, and Katerina Artavanis-Tsakonas, and Eva-Maria Frickel, and Christine E Becker, and Zeina Dagher, and You-Me Kim, and Eicke Latz, and Hidde L Ploegh, and Michael K Mansour, and Cindy K Miranti, and Stuart M Levitz, and Jatin M Vyas
January 2013, PloS one,
Nida S Khan, and Daniel P Lukason, and Marianela Feliu, and Rebecca A Ward, and Allison K Lord, and Jennifer L Reedy, and Zaida G Ramirez-Ortiz, and Jenny M Tam, and Pia V Kasperkovitz, and Paige E Negoro, and Tammy D Vyas, and Shuying Xu, and Melanie M Brinkmann, and Mridu Acharaya, and Katerina Artavanis-Tsakonas, and Eva-Maria Frickel, and Christine E Becker, and Zeina Dagher, and You-Me Kim, and Eicke Latz, and Hidde L Ploegh, and Michael K Mansour, and Cindy K Miranti, and Stuart M Levitz, and Jatin M Vyas
November 2014, Zhonghua yi xue za zhi,
Copied contents to your clipboard!